Rilmenidine prevents blood pressure increase in rats with compromised nitric oxide production

Acta Pharmacologica Sinica

Volumn 25, Issue 12, 2004, Pages 1640-1646

  Gerová, Mária ^a   Török, Jozef ^a   Pecháòová, Ol'ga ^a   Matušková, Jana ^b,c  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hypertension; Imidazoline receptor; Nitric oxide synthase; NO deficiency; Sympathetic activity

Indexed keywords

ACETYLCHOLINE; IMIDAZOLINE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RILMENIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE MEASUREMENT; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; EXPERIMENTAL MODEL; HEART LEFT VENTRICLE; HYPERTENSION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; BLOOD PRESSURE; BRAIN; ENDOTHELIUM, VASCULAR; HEART VENTRICLES; HYPERTENSION; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXAZOLES; RATS; RATS, WISTAR; RECEPTORS, DRUG;

EID: 10344220524     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bayliss C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-81.
2. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20: 298-303.
3. Bernátová I, Pecháòová O. NO-deficient hypertension induced by L-NAME treatment in rats. J Mol Cell Cardiol 1994; 26: CXXIII (abstract).
4. Li JS, Schiffrin EL. Resistance artery structure and neuro-effector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens 1994; 7: 996-1004.
5. Lüscher TF, Vanhoutte PM. The endothelium modulator of cardiovascular function. Boca Raton: CRG Press; 1991. p 1-228.
6. Gerová M, Kristek F. Efficiency of NO donors in substituting impaired endogenous NO production: a functional and morphological study. Physiol Res 2001; 50: 165-73.
7. Török J, Kristek F. Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vascular Pharmacol 2002; 38: 177-82.
8. Morton JJ, Beattie EC, Speirs A, Gulliver F. Persistent hypertension following inhibition of NO formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens 1993; 11: 1083-8.
9. Bernátová I, Pecháòová O, Šimko F. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 1999; 84: 1095-105.
10. Gerová M, Mašánová C, Pavlásek J. Inhibition of NO synthase in the posterior hypothalamus increases blood pressure in the rat. Physiol Res 1995; 44: 131-4.
11. Shapoval LN, Sagach VF, Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991; 132; 47-50.
12. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 1995; 26: 691-5.
13. Gerová M, Hartmannová B, Doleel S, Jeek L. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation. Physiol Res 1996; 45: 339-44.
14. Liu Y, Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats. J Hyperten 1998; 16: 1165-73.
15. 2-adrenoceptors in the ventrolateral medulla. Eur J Pharmacol 1987; 134: 1-13.
16. Molderings GJ, Gothert M. Imidazoline binding sites and receptors in cardiovascular tissue. Gen Pharmacol 1999; 32: 17-22.
17. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996; 79: 363-80.
18. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, et al. Localization of nitric oxide synthase in the adult rat brain. Phil Trans R Soc Long B 1994; 345: 175-221.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
20. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-5.
21. Bricca G, Dontenwill M, Molines A, Feldman J, Belcourt A, Bousquet P. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur J Pharmacol 1989; 162: 1-9.
22. Gomez RE, Ernsberger P, Feinland G, Reis DJ. Rimenidine lowers arterial pressure via imidazoline receptors in brainstem C1 area. Eur J Pharmacol 1991; 195: 181-91.
23. Sy GY, Bruban V, Bousquet P, Feldman J. Nitric oxide nad central antihypertensive drugs: one more difference between catecholamines and imidazolines. Hypertension 2001; 37: 246-9.
24. Zhang T, Johns EJ. Rilmenidine and reflex renal sympathetic nerve activation in Wistar and hypertensive rats. Br J Pharmacol 1996; 119: 1248-54.
25. Scares De Moura RS, Leao MC, Castro Resende AC, Moreira CF, Sena KM, Silveira SS, et al. Actions of L-NAME and methylene blue on the hypotensive effects of clonidine and rilmenidine in the anesthetized rat. J Cardiovasc Pharmacol 2000; 35: 791-5.
26. Artigues-Varin C, Richard V, Varin R, Mulder P, Thuillez C. Alpha2-adrenoceptor ligans inhibit alpha1-adrenoceptor-mediated contraction of isolated rat arteries. Fundam Clin Pharmacol 2002; 16: 281-7.
27. Griscavage JMA, Hobbs AJ, Ignarro LJ. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol 1995; 34: 215-34.
28. Yuhanna IS, Macritchie AN, Lantin-Hermoso RL, Wells LB, Shaul PW. Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1999; 21: 629-36.
29. De Gennaro Coronna V, Rossoni G, Rigamonti A, Bonomo S, Manfredi B, Berti F, et al. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol 2002; 450: 61-6.